About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Hypertension Clinical Trials in Los Angeles | 83 Studies

Clinical Trials HypertensionLos Angeles

Hypertension Clinical Trials in Los Angeles

Find 83 clinical trials for hypertension near Los Angeles, California. Connect with research centers in your area.

All Hypertension trials nationwide All trials in Los Angeles

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 83 trials

CompletedOpen-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using TyvasoThis was a Phase 1b safety and tolerability single-sequence study in which PAH subjects on a stable regimen of Tyvaso switched to a corresponding dose of TreT.NCT03950739·Birmingham, Alabama and 15 others CompletedFibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)Noninvasive monitoring of liver fibrosis is an unmet need within the clinical management of pediatric chronic liver disease.NCT02922751·Los Angeles, California and 12 others

Hypertension Trials in Other Cities

New York Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

RecruitingDe-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic HerniaThe purpose of this study is to determine if de-implementation of inhaled nitric oxide (iNO) in the post-natal resuscitation/stabilization phase affects the composite outcome of…NCT05213676·Birmingham, Alabama and 18 others

RecruitingPharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults…NCT04278404·Phoenix, Arizona and 51 others

Active not recruitingExtension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of TreprostinilThe primary objective of this study is to evaluate the long-term safety of LIQ861 in patients with pulmonary arterial hypertension (PAH).NCT03992755·Phoenix, Arizona and 24 others

Active not recruitingOpen-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With HypertensionThis study is to evaluate the long-term safety, efficacy and tolerability of lorundrostat (an aldosterone synthase inhibitor) in subjects with hypertensionNCT05968430·Birmingham, Alabama and 176 others

TerminatedA Study With BPS-314d-MR-PAH-303 in Participants With Pulmonary Arterial HypertensionThis is a multi-center, open-label study for eligible participants who were actively participating in the BPS-314d-MR-PAH-302 double-blind study (NCT01908699) at the time the…NCT03657095·Birmingham, Alabama and 44 others

CompletedClinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT InstrumentSYMPHONY is prospective, multi-center, open-label, single-arm, Phase 3b psychometric validation study of the PAH-SYMPACT, a new quality of life questionnaire for patients with…NCT01841762·Birmingham, Alabama and 80 others

CompletedA Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary HypertensionThis is a prospective, randomized, parallel group study to assess the hemodynamic effect of three different dose regimens of a sustained release (SR) tablet of UT-15C in patients…NCT01104870·Phoenix, Arizona and 8 others

CompletedEfficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial HypertensionThis study is an international, multi-center, randomized, double-blind, placebo-controlled study in subjects with PAH who are currently receiving approved therapy for their PAH…NCT00887978·Birmingham, Alabama and 61 others

CompletedSelonsertib in Adults With Pulmonary Arterial HypertensionThe primary objective of this study is to evaluate the effect of selonsertib (GS-4997) on pulmonary vascular resistance (PVR), as measured by right heart catheterization (RHC) in…NCT02234141·Mobile, Alabama and 45 others

TerminatedClinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAHPhase 3, placebo controlled, double-blind, randomized clinical study to determine safety, tolerability, and efficacy of pulsed, inhaled nitric oxide (iNO) versus placebo in…NCT02725372·Phoenix, Arizona and 108 others

CompletedInvestigation of the Safety and Pharmacology of Dry Powder Inhalation of TreprostinilThe primary objective of this study is to evaluate the long-term safety and tolerability of LIQ861, a dry powder formulation of treprostinil, in patients with Pulmonary Arterial…NCT03399604·Phoenix, Arizona and 37 others

WithdrawnFREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)This study is an international, multi-center, randomized, double-blind, placebo-controlled study in subjects with PAH who are currently receiving approved therapy for their PAH…NCT00760916·Birmingham, Alabama and 30 others

CompletedA Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329This study will characterize the effect of PF-04217329, alone and in combination with latanoprost, on circadian intraocular pressure and blood pressure in glaucoma patients.NCT00934089·Cypress, California and 7 others

TerminatedRemodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the NewbornThis study assessed the safety and treatment effect of intravenous (IV) Remodulin as an add-on therapy in neonates with persistent pulmonary hypertension of the newborn (PPHN).NCT02261883·Little Rock, Arkansas and 13 others

RecruitingTreatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension SystemThis prospective study is a multi-center early feasibility study assessing the safety and performance of the Aria CV Pulmonary Hypertension System in patients with pulmonary…NCT04555161·La Jolla, California and 11 others

CompletedAssess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial HypertensionTo assess the efficacy and safety of sildenafil when added to patients with PAH who are taking bosentan as all or part of their background therapy.NCT00323297·Los Angeles, California and 29 others

TerminatedExtended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGERThis extended access study will assess the long-term safety and tolerability of bardoxolone methyl in qualified patients with pulmonary hypertension (PH) who previously…NCT03068130·Phoenix, Arizona and 95 others

CompletedSYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled HypertensionThe Symplicity HTN-3 study is a, multi-center, prospective, single-blind, randomized, controlled study of the safety and effectiveness of renal denervation in subjects with…NCT01418261·Birmingham, Alabama and 78 others

PreviousPage 3 of 5Next

Other Conditions in Los Angeles

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia